Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 3 September 2019. Beth McQuiston.

Executive Summary

A landmark study of Abbott's point-of-care blood test for traumatic brain injuries shows the test could identify patients who should undergo magnetic resonance imaging (MR) even after a computed tomography (CT) scan did not show a brain injury. See what Beth McQuiston, medical director for Abbott Diagnostics' division said about it here.

“We've got a blood test for [injuries to] the heart, the liver, and the kidneys; it's about time we had one for the brain. Any technology that is being used or considered should be built on robust proven research and validation, and that’s why a landmark study like this is exciting.” – Beth McQuiston, medical director, Abbott Diagnostics

Click here for a free trial of Medtech Insight


Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts